Eva Långström-Einarsson (Former)
1 – 5 of 10
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
- 1996
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article
- 1993
-
Mark
Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix
(
- Contribution to journal › Article
- 1992
-
Mark
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas
(
- Contribution to journal › Article